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Abstract
Background: Primary ciliary dyskinesia (PCD) is a relatively rare autosomal reces-
sive or X‐linked disorder affecting ciliary function. In the set of causative genes, 
however, predominant pathogenic variants remain unknown in Asia.
Method: A diagnosis of PCD was made following a modern comprehensive test-
ing including genetic analysis; targeted resequencing for screening variants, and 
Sanger sequencing for determination of the breakpoints, with an additional review 
of databases to calculate the deletion frequency. A multiplexed PCR‐based detection 
method has also been developed.
Results: We ascertained a 50‐year‐old Japanese male who had been diagnosed with 
diffuse panbronchiolitis (DPB), but refractory to macrolide therapy. We reevaluated 
the case and identified a large homozygous deletion spanning exons 1 to 4 of the DRC1 
and determined the breakpoints (NM_145038.4: c.1‐3952_540 + 1331del27748‐bp). 
In the PCD cohort at the University of North Carolina, we found a female PCD pa-
tient of Korean descent harboring the same homozygous deletion. From the Invitae 
testing cohort, we extracted four carriers of the same deletion among 965 Asian indi-
viduals, whereas no deletion was found in the 23,951 non‐Asians.
Conclusion: We speculate that the DRC1 deletion is a recurrent or perhaps founder 
mutation in Asians. The simple PCR method could be a useful screening tool.
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1 |  INTRODUCTION
Primary ciliary dyskinesia (PCD, MIM 244400) is a rela-
tively rare autosomal recessive or X‐linked disorder caused 
by abnormalities of motile cilia in the respiratory tract and 
other organs, and of sperm flagella, with an incidence of 
10,000–20,000 per birth (Zariwala, Knowles, & Leigh, 2015). 
Clinical manifestations include chronic rhinosinusitis, recur-
rent respiratory infections, infertility, and laterality defects. 
In addition to classical electron microscopy (EM) analysis 
of ciliary ultrastructure, nasal nitric oxide (nNO) measure-
ments, and genetic analysis are used for diagnosis at well‐
equipped PCD centers (Knowles, Zariwala, & Leigh, 2016; 
Shapiro et al., 2018); whereas, these tests are rarely available 
in many countries including Japan (European Respiratory 
Journal 2018 52: PA4427).
In East Asia, diffuse panbronchiolitis (DPB) is well‐
known as a multifactorial disease characterized by sino‐pul-
monary infection/inflammation with genetic predisposition 
unique to Asians (Keicho & Hijikata, 2011; Keicho et al., 
2000). Although long‐term macrolide therapy dramatically 
improved the prognosis of the disease in 1980s (Kudoh, 
Azuma, Yamamoto, Izumi, & Ando, 1998), there still re-
mains DPB patients who are resistant to treatment.
Here, we describe a Japanese PCD patient who had ini-
tially been misdiagnosed as refractory DPB. While the cil-
iary ultrastructure was normal, low levels of nNO prompted 
us to analyze a panel of PCD genes. A novel homozygous 
deletion spanning exons 1 to 4 of the DRC1 (dynein regu-
latory complex subunit 1, NM_145038.4, [OMIM615288]) 
was identified (Wirschell et al., 2013; Zariwala et al., 2015). 
We subsequently reviewed the University of North Carolina 
(UNC) PCD cohort and found the same homozygous deletion 
in a patient of Korean origin. Identification of this multi‐exon 
deletion in several individuals of Asian descent strongly sug-
gests that it is recurrent and possibly a founder mutation in 
the Asian population. A PCR‐based screening method for 
this deletion is also proposed here as a useful tool to detect 
this deletion.
2 |  MATERIAL AND METHODS
A signed and informed consent was obtained from all the 
participants in this study. All protocols involving human 
studies were approved by the University of North Carolina 
Medical School Review Board. This study was approved 
by each institutional review board (Institutional review 
board number 16,024 at Fukujuji Hospital, Japan Anti‐
Tuberculosis Association (JATA), RIT/IRB 28–20 at the 
Research Institute of Tuberculosis, JATA, and 20,161,796 at 
Invitae Corporation). Detailed information about the patients 
and the diagnostic procedures including genetic analysis are 
documented in Supporting Information: Briefly, based on 
prior observation of normal EM findings of nasal cilia from 
the first Japanese case, his genomic DNA was subjected to 
targeted resequencing analysis of four genes that are known to 
cause PCD without ultrastructural changes of cilia. The PCR 
primers for resequencing are shown in Table S1. Breakpoints 
of the large deletion of DRC1 were further determined in the 
first case by Sanger sequencing and confirmed in the second 
case at UNC. Multiplexed PCR‐based method was also de-
veloped to screen the deletion. The frequency of the DRC1 
deletion was assessed in a total of 24,916 individuals (49,832 
total alleles) who had been tested for PCD and non‐PCD phe-
notypes at Invitae Corporation; ethnicity data for these indi-
viduals was self‐reported (see Supporting Information).
3 |  RESULTS
3.1 | Clinical features of the first case and 
identification of a novel DRC1 mutation
A 50‐year‐old male (case 1) was referred to Fukujuji Hospital 
because his productive cough and dyspnea had worsened 
over a few months. The patient was diagnosed with DPB 
in his late 40 s at a nearby hospital, based on clinical find-
ings, including chronic rhinosinusitis, bilateral centrilobular 
lesions indicating diffuse bronchiolitis, and obstructive im-
pairment in the pulmonary function test. He was a never‐
smoker and did not have any history of rheumatoid arthritis 
or Sjögren's syndrome. There was no known consanguinity. 
No situs abnormalities were identified. He had borderline 
hypoxemia (oxygen saturation 91%) under 0.5 L/min oxy-
gen supplementation. Physical examination revealed coarse 
crackles in the lung fields. Chest X‐ray showed diffuse gran-
ular and reticular shadows with hyperinflation in both lungs. 
Chest CT scanning showed diffuse bronchiectasis, mainly in 
the middle lobe (Figure 1). Sinus CT scans were indicative of 
chronic sinusitis. In most patients with DPB, treatment with 
clarithromycin leads to dramatic improvement. However, 
this case was refractory to this treatment. We further noticed 
that he had a history of fertility treatment, and suspected 
PCD. We attempted comprehensive tests for diagnosis of 
PCD, following the current guidelines: EM findings showed 
a slightly decreased number of inner dynein arms of the cilia 
but within normal limit (Figure 1), whereas nNO level was 
low (5.27 nl/min).
By genetic approach, we focused on sequencing PCD‐
causative genes that do not affect ciliary ultrastructure 
(DNAH11, DRC1, CCDC65, GAS8, and HYDIN), which ul-
timately revealed that zero reads mapped to exons 1 to 4 of 
DRC1 suggesting presence of a homozygous deletion encom-
passing these exons (Figure S1a). The genomic region en-
compassing the deletion was amplified by PCR (Figure S1b), 
and direct Sanger sequencing of the PCR product revealed 
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a 27,748  bp deletion with breakpoints shown in Figure 2 
(NM_145038.4: c.1‐3952_540  +  1331del27748‐bp). We 
sebsequently excluded other genetic causes of PCD (DNAH5, 
DNAI1, CCDC39, CCDC40, C21orf59, DNAAF1, DNAAF2, 
DNAAF3, DNAAF4, DNAAF5, LRRC6, SPAG1, ZMYND10, 
CCNO, RSPH1, RSPH3, RSPH9, RSPH4A, ARMC4, 
CCDC103, CCDC151, DNAI2, DNAL1, NME8, CCDC114, 
PIH1D3, DNAJB13, TTC25).
3.2 | Discovery of the second case of the 
same DRC1 deletion in PCD cohort at UNC
Since our first patient carried a novel, homozygous gross de-
letion in DRC1, we reviewed similar cases in the UNC cohort 
(Supporting Information) with the consideration that this de-
letion may be recurrent in the Asian population.
A 5‐year‐old girl (case 2) of Korean descent with bron-
chiectasis was referred to UNC for evaluation for possible 
PCD. She was born in South Korea but was adopted by a 
family in the United States at 13 months of age. She had 
daily, year‐round wet cough and daily, year‐round nasal 
congestion and drainage since infancy. She had no lateral-
ity defect. She had a chest CT scan at 4.5 years of age that 
showed bronchiectasis in the right middle lobe, the right 
lower lobe, and lingula. Evaluation for primary ciliary dys-
kinesia included low nNO level (8 nl/min), and normal cil-
iary ultrastructure on EM.
Based on the positions of breakpoints identified in case 
1, the genomic region containing the deletion of DRC1 in 
case 2 was amplified by PCR and sequenced to confirm the 
deleted region and breakpoints (Figure S2). A multiplexed 
PCR‐based method showed the amplification of a single 
515 bp fragment from both cases 1 and 2, which indicated the 
homozygosity of the deletion allele; control genomic DNA 
show three fragments from the wild type allele (Figure S3).
3.3 | Ethnicity of the individuals with the 
large DRC1 deletion in genetic test panels 
at Invitae
Here, we have identified two individuals with PCD of 
Asian descent who are homozygous for the DRC1 exon 
1–4 deletion (cases 1 and 2). In the Invitae database, an 
additional four individuals were found to be heterozygous 
for the DRC1 large deletion. Thus, the overall minor allele 
frequency (MAF) of the deletion in the Invitae cohort was 
calculated to be 0.012% (6/49,832). When including only 
those individuals who self‐reported as Asian (965 individ-
uals), the ethnic specific MAF was calculated to be 0.31% 
(6/1,930; 95% CI using Wilson method: 0.14%–0.68%). 
Importantly, the MAF in Asians was significantly higher 
than other self‐reported ethnicities, i.e. white or Caucasian 
95% CI MAF: 0%–0.025%.
4 |  DISCUSSION
In the present study, we report a novel 28‐kb deletion in 
DRC1, a PCD causative gene, carried by Asian patients. Case 
1 was initially diagnosed as DPB with respiratory failure, 
and refractory against macrolide treatment. Surprisingly, 
nNO levels were low despite no detectable ultrastructural 
abnormalities in cilia, and a large homozygous deletion in 
DRC1 was identified by targeted resequencing approach. A 
unique group of genes causative for PCD and encoding sub-
unit proteins involving nexin links and the dynein regulatory 
F I G U R E  1  Radiological and electron 
microscopy findings of case 1 of primary 
ciliary dyskinesia. (a) Chest X‐ray showing 
nodular shadows with tramlines and 
consolidation predominantlyin the lower 
lung field. (b) Chest CT scans showing 
small nodules and bronchiectasis in the 
both lung field. (c) Transmission electron 
micrograph showing of a ciliary cross 
section showing normal 9 + 2 microtubular 
arrangement and presence of both inner and 
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complex (N‐DRC) have a peculiar characteristic of normal 
EM findings except for invisible nexin links (Shapiro & 
Leigh, 2017). In addition, DRC1 mutations, including cases 
1 and 2 reported here, have not been reported to cause lat-
erality defects (Knowles et al., 2016). This is consistent 
with mutations in other N‐DRC related genes CCDC65 
and GAS8. Importantly, if ciliary ultrastructural EM were 
the sole diagnostic method used for the individuals in this 
report, they would have been misdiagnosed with refractory 
DPB since macrolide treatment is known to fail for patients 
diagnosed with PCD. It is thus essential to evaluate indi-
viduals suspected to have PCD comprehensively based on 
the current guidelines, including appropriate genetic testing.
The same homozygous gross deletion of DRC1 was observed 
in two cases. The case 2 had respiratory symptoms within one 
day after birth. Consistent with earlier reports, DRC1 mutations 
may often lead to early onset of the disease (Wirschell et al., 
2013). Considering the diagnostic delay in case 1, awareness 
of PCD might be low among health care providers in Japan and 
other countries; further education in these countries will be im-
portant for early diagnosis and timely treatment of patients with 
PCD. Establishment of a standard diagnostic process in these 
countries is also absolutely essential.
The prevalence of DRC1‐related PCD is estimated to be <1% 
in Western literature reports (Zariwala et al., 2015). Importantly, 
all individuals with the DRC1 exon 1–4 deletion observed in this 
study are of Asian descent. In addition, a nearly identical deletion 
(Chr2:26398037–26425785, esv2657536) has been reported in 
Japanese (JPT) individual NA19080 of the 1,000 genomes data-
base (http://www.1000g enomes.org/). As a result, we speculate 
that this variant is a founder mutation in the Asian population, 
although analyses of a large number of definitive cases (Takeuchi 
et al., 2018) and haplotype analysis on a large dataset will be re-
quired to demonstrate this conclusively. Considering ethnicity of 
the two homozygotes reported herein, it is likely that the DRC1 
deletion is highly recurrent in East Asian populations, particu-
larly in Koreans and Japanese with a similar genetic background 
based on HLA typing results(Keicho & Hijikata, 2011; Keicho et 
al., 2000), although future research into the ethnic specific popu-
lation frequency of this deletion is needed.
In summary, we found two PCD cases homozygous for a 
gross deletion in DRC1: a Japanese male and a Korean female. 
F I G U R E  2  Breakpoints of the deletion in DRC1 determined in case 1. A genomic region containing the deletion was amplified by PCR and 
directly sequenced as described in Supporting Information, and the deletion breakpoints were determined
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In addition, four individuals of Asian descent were found to be 
carriers. Case 1 had been treated as a refractory case of DPB 
for years. The correct diagnosis of PCD caused by the DRC1 
deletion was made by the methods including nNO and genetic 
analysis. With our research presented here, we show that the 
DRC1 deletion was detected only in Asians. Together with 
our two cases, we speculate that this is a founder mutation in 
Asians. Given the likely recurrent nature of the DRC1 dele-
tion, our screening PCR method could be a useful approach for 
Asian patients suspected of PCD and refractory DPB.
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